Neurable Inc. is a Boston-based neurotechnology company specializing in developing AI-powered tools for brain signal translation and brain-computer interface technology (BCI). Powered by patented signal processing, developed through years of pioneering research across leading labs and institutions, and advanced by a leading scientific and expert product team, the Neurable AI platform enables high-performance brain-computer interface in everyday devices. This is the first time technology of this caliber will be available in compact form factors rather than traditional external brain wave monitoring devices.

Neurable is dedicated to creating a world where individuals can better understand their minds, optimize human performance, and conquer the most pressing health challenges of our generation. Having secured over $30 million in funding since its inception, and earning validation from the US Air Force, the company continues to work with its licensing partnership network to make non-invasive BCI technology the standard in everyday devices across multiple industries. Neurable has also teamed up with Healthspan Digital Inc. to bring advanced brain health tools to longevity clinics across the globe and remains committed to tackling more global health challenges, from disease detection and treatment to drug development and more.